Neuralstem (CUR) Pops Higher as Traders Pass Around "Amazing Results" Article
Tweet Send to a Friend
Up)
Shares of Neuralstem (NYSE: CUR) are seeing mid-day action with the move being attributed to an Crain's article dated November 30, 2012 making the rounds. The article discusses positive results from the company's stem-cell injections.
In addition, there is a stem cell conference ongoing in West Palm Beach, Florida.
Shares of CUR are up 7 percent mid-day to $1.34.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
In addition, there is a stem cell conference ongoing in West Palm Beach, Florida.
Shares of CUR are up 7 percent mid-day to $1.34.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- Herbalife (HLF) Active on Chatter
- Royalty Pharma Raises Elan (ELN) Bid to $12.50/share
Create E-mail Alert Related Categories
Trader Talk
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
